Francesco M. Turrini
Sassari, 07100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Real-time PCR-based detection of Mycoplasma agalactiae in sheep bulk tank milk to support flock-level epidemiology.
Journal: Veterinary research communications
Published: February 09, 2026
Comparison of microbiological and molecular diagnosis for identification of respiratory secondary infections in COVID-19 patients and their antimicrobial resistance patterns.
Journal: Diagnostic microbiology and infectious disease
Published: July 16, 2024
Nrf2 Plays a Key Role in Erythropoiesis during Aging.
Journal: Antioxidants (Basel, Switzerland)
Published: March 15, 2024
Reduced cyclin D3 expression in erythroid cells protects against malaria.
Journal: Nature
Published: February 21, 2024
A new molecular method for rapid etiological diagnosis of sepsis with improved performance.
Journal: Future microbiology
Published: June 04, 2021
Imatinib augments standard malaria combination therapy without added toxicity.
Journal: The Journal of experimental medicine
Published: April 01, 2021
Tyrosine Phosphorylation Modulates Peroxiredoxin-2 Activity in Normal and Diseased Red Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: November 29, 2020
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.
Journal: The Journal of clinical investigation
Published: September 14, 2020
Syk Inhibitors: New Computational Insights into Their Intraerythrocytic Action in Plasmodium falciparum Malaria.
Journal: International journal of molecular sciences
Published: July 17, 2020
Syk Kinase Inhibitors Synergize with Artemisinins by Enhancing Oxidative Stress in Plasmodium falciparum-Parasitized Erythrocytes.
Journal: Antioxidants (Basel, Switzerland)
Published: July 15, 2020
Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.
Journal: PloS one
Published: June 17, 2020
Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
Journal: British journal of haematology
Published: January 16, 2020
Last Updated: 09/26/2026